Feb. 13 (UPI) --Regenerative medicine company Frequency Therapeutics announced Monday it will scrap development of a drug called FX-322, after testing failed to show improvement in speech perception ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results